Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-11-07

FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approved a new original application for the combination product omeprazole and sodium bicarbonate (Aurohealth LLC) intended for gastroesophageal reflux dise…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omeprazole and sodium bicarbonate (omeprazole and sodium bicarbonate)

Snippet

ORIG AP for OMEPRAZOLE AND SODIUM BICARBONATE (OMEPRAZOLE AND SODIUM BICARBONATE)